| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |